
{{header
| author     = | override_author = United States Congress
| translator = 
| section    = 
| previous   = 
| next       = 
| year       = 
| notes      = ''{{USBill|113|s|77}}''
| categories =
| portal     =
| congress       = 113
| session        = 1
| title          = Prescription Drug and Health Improvement Act of 2013 ( s77 ; 113th Congress)

| year           = 2013
| month          = 01
| day            = 23
| bill           = 77
| billtype       = s
| purpose        = To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate for lower prices for Medicare prescription drugs.
}}

{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|S. 77}}


{{Center|IN THE SENATE OF THE UNITED STATES}}


{{Center|January 23 (legislative day, January 3), 2013}}


{{Center|
[[w:|Mr. Franken]] (for himself and
[[w:|Ms. Klobuchar]] ) introduced the following bill; which was read twice and referred to the [[w:United States Senate Committee on Finance|Committee on Finance]] }}


{{Center|A BILL}}

To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate for lower prices for Medicare prescription drugs.

={{anchor|idD874E100A4184C7F8B22AB8526AEEA7E}}Section 1. Short title=

This Act may be cited as the“Prescription Drug and Health Improvement Act of 2013”.

={{anchor|id09832F88937D4F18BC6BBC61D90B5858}}Sec. 2. Negotiating fair prices for medicare prescription drugs=



=={{anchor|IDD957981F6BE741E382087FD1FE0B860C}}(a) Negotiating fair prices– ==



==={{anchor|id8A7503A3469F44F5B96828557B005632}}(1) In general– ===

 Section 1860D–11 of theSocial Security Act([http://www.law.cornell.edu/uscode/text/42/1395w–111 42 U.S.C. 1395w–111] )is amended by striking subsection (i)(relating to noninterference) and by inserting the following:

<blockquote>

===={{anchor|ID73AC92EA6D0F4DD9A877301D1B94A701}}(i) Authority To negotiate prices with manufacturers– ====

In order to ensure that beneficiaries enrolled under prescription drug plans and MA–PD plans pay the lowest possible price, the [[w:Department of Health and Human Services|Secretary]] shall have authority similar to that of other Federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs, consistent with the requirements and in furtherance of the goals of providing quality care and containing costs under this part..
</blockquote>


==={{anchor|IDC939CBFA45324369946A0D21C8C71757}}(2) Effective date– ===

The amendment made by paragraph (1)shall take effect on the date of the enactment of this Act.

=={{anchor|IDeda4019c386d427abb844f4e4718f0f9}}(b) Biannual reports to Congress– ==

Not later than 1 year after the date of the enactment of this Act, and every 6 months thereafter, the [[w:Department of Health and Human Services|Secretary of Health and Human Services]] shall submit to [[w:United States Congress|Congress]] a report on the negotiations conducted by the [[w:Department of Health and Human Services|Secretary]] under section 1860D–11(i) of the Social Security Act([http://www.law.cornell.edu/uscode/text/42/1395w–111 42 U.S.C. 1395w–111(i)] ), as amended by subsection (a), including a description of how such negotiations are achieving lower prices for covered part D drugs (as defined in section 1860D–2(e) of theSocial Security Act([http://www.law.cornell.edu/uscode/text/42/1395w–102 42 U.S.C. 1395w–102(e)] )) for Medicare beneficiaries.